Home NextCure

NextCure

In operation
Seasoned Equity Offering
Immunotherapy Developer

Basic Information

NextCure is a biopharmaceutical company dedicated to discovering and developing first-in-class immunomedicines for the next generation of cancer and other disease treatments. It can fully leverage the "functional" identification of targets that may influence immune responses through its FIND-IO™ technology, establishing a new process for immunotherapy.
NextCure, Inc.
Maryland,United States of America
51~100 people
January 01, 2015
busdev@nextcure.com